NZ515999A - Biologically active materials - Google Patents
Biologically active materialsInfo
- Publication number
- NZ515999A NZ515999A NZ515999A NZ51599900A NZ515999A NZ 515999 A NZ515999 A NZ 515999A NZ 515999 A NZ515999 A NZ 515999A NZ 51599900 A NZ51599900 A NZ 51599900A NZ 515999 A NZ515999 A NZ 515999A
- Authority
- NZ
- New Zealand
- Prior art keywords
- biologically active
- active materials
- polymer
- drug conjugate
- dextrin
- Prior art date
Links
- 239000011149 active material Substances 0.000 title 1
- 229920001353 Dextrin Polymers 0.000 abstract 2
- 239000004375 Dextrin Substances 0.000 abstract 2
- 235000019425 dextrin Nutrition 0.000 abstract 2
- 229920000642 polymer Polymers 0.000 abstract 2
- 239000000580 polymer-drug conjugate Substances 0.000 abstract 2
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
- A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9914187.1A GB9914187D0 (en) | 1999-06-18 | 1999-06-18 | Biologically active materials |
| GBGB9930252.3A GB9930252D0 (en) | 1999-12-22 | 1999-12-22 | Biologically active molecules |
| PCT/GB2000/002216 WO2000078355A2 (en) | 1999-06-18 | 2000-06-19 | Biologically active materials |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ515999A true NZ515999A (en) | 2004-03-26 |
Family
ID=26315678
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ515999A NZ515999A (en) | 1999-06-18 | 2000-06-19 | Biologically active materials |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6818630B1 (enExample) |
| EP (1) | EP1198253A2 (enExample) |
| JP (1) | JP2003504312A (enExample) |
| AU (1) | AU783886B2 (enExample) |
| CA (1) | CA2374548A1 (enExample) |
| HK (1) | HK1047884A1 (enExample) |
| IL (1) | IL146795A0 (enExample) |
| MX (1) | MXPA01013276A (enExample) |
| NO (1) | NO20016147L (enExample) |
| NZ (1) | NZ515999A (enExample) |
| WO (1) | WO2000078355A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8106098B2 (en) | 1999-08-09 | 2012-01-31 | The General Hospital Corporation | Protein conjugates with a water-soluble biocompatible, biodegradable polymer |
| WO2002020663A2 (en) | 2000-09-06 | 2002-03-14 | Ap Pharma, Inc. | Degradable polyacetal polymers |
| DE10112825A1 (de) | 2001-03-16 | 2002-10-02 | Fresenius Kabi De Gmbh | HESylierung von Wirkstoffen in wässriger Lösung |
| DE10129369C1 (de) | 2001-06-21 | 2003-03-06 | Fresenius Kabi De Gmbh | Wasserlösliches, einen Aminozucker aufweisendes Antibiotikum in Form eines Pol ysaccharid-Konjugats |
| DE60323936D1 (de) | 2002-01-14 | 2008-11-20 | Gen Hospital Corp | Bioabbaubare polyketale, verfahren zu ihrer herstellung sowie ihre verwendung |
| DE10209821A1 (de) | 2002-03-06 | 2003-09-25 | Biotechnologie Ges Mittelhesse | Kopplung von Proteinen an ein modifiziertes Polysaccharid |
| US8030459B2 (en) | 2002-07-19 | 2011-10-04 | The General Hospital Corporation | Oxime conjugates and methods for their formation and use |
| DE60323756D1 (de) | 2002-10-08 | 2008-11-06 | Fresenius Kabi De Gmbh | Pharmazeutisch aktive oligosaccharid-conjugate |
| US7947261B2 (en) * | 2003-05-23 | 2011-05-24 | Nektar Therapeutics | Conjugates formed from polymer derivatives having particular atom arrangements |
| WO2005014655A2 (en) | 2003-08-08 | 2005-02-17 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein |
| DE602004032553D1 (de) * | 2003-09-05 | 2011-06-16 | Gen Hospital Corp | Polyacetal-arzneimittelkonjugate als freisetzungssystem |
| PA8853201A1 (es) | 2008-12-10 | 2010-07-27 | Mersana Therapeutics Inc | Formulaciones farmaceuticas de conjugados de camtotecina-polimero biocompatibles biodegradables |
| KR102366322B1 (ko) | 2020-07-31 | 2022-02-22 | 주식회사 다산네트웍스 | 전기자전거 주행시스템 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69103503T2 (de) * | 1990-09-28 | 1995-01-05 | Mercian Corp | Adriamycinderivate. |
| WO1995005199A1 (en) * | 1993-08-19 | 1995-02-23 | Dextran Products Limited | Pharmaceutical preparation and a process for making same |
| IT1281877B1 (it) | 1995-05-10 | 1998-03-03 | Fidia Advanced Biopolymers Srl | Sali di metalli pesanti di succinil derivati dell'acido ialuronico e loro impiego come potenziali agenti terapeutici |
| US6338843B1 (en) * | 1997-06-12 | 2002-01-15 | Ml Laboratories | Biologically active materials |
-
2000
- 2000-06-19 IL IL14679500A patent/IL146795A0/xx unknown
- 2000-06-19 JP JP2001504417A patent/JP2003504312A/ja active Pending
- 2000-06-19 HK HK02107706.8A patent/HK1047884A1/zh unknown
- 2000-06-19 CA CA002374548A patent/CA2374548A1/en not_active Abandoned
- 2000-06-19 NZ NZ515999A patent/NZ515999A/xx unknown
- 2000-06-19 WO PCT/GB2000/002216 patent/WO2000078355A2/en not_active Ceased
- 2000-06-19 US US10/018,608 patent/US6818630B1/en not_active Expired - Fee Related
- 2000-06-19 MX MXPA01013276A patent/MXPA01013276A/es unknown
- 2000-06-19 EP EP00938905A patent/EP1198253A2/en not_active Withdrawn
- 2000-06-19 AU AU54130/00A patent/AU783886B2/en not_active Ceased
-
2001
- 2001-12-17 NO NO20016147A patent/NO20016147L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003504312A (ja) | 2003-02-04 |
| AU5413000A (en) | 2001-01-09 |
| HK1047884A1 (zh) | 2003-03-14 |
| AU783886B2 (en) | 2005-12-22 |
| CA2374548A1 (en) | 2000-12-28 |
| NO20016147L (no) | 2002-01-29 |
| NO20016147D0 (no) | 2001-12-17 |
| WO2000078355A3 (en) | 2002-02-21 |
| EP1198253A2 (en) | 2002-04-24 |
| US6818630B1 (en) | 2004-11-16 |
| IL146795A0 (en) | 2002-07-25 |
| MXPA01013276A (es) | 2002-06-04 |
| WO2000078355A2 (en) | 2000-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ515999A (en) | Biologically active materials | |
| EP1374908A3 (en) | Polymer-drug conjugates comprising hydrazide linkers | |
| BG106030A (en) | Pharmaceutical composition | |
| AU6845300A (en) | Novel multilayered material bearing a biologically active agent and the preparation thereof | |
| DE69721481D1 (de) | Wirkstoffformulierungen mit verzögerter freisetzung | |
| DE69835201D1 (en) | Neoglycoproteine | |
| ATE192736T1 (de) | (2,4-disulfophenyl) n-tertiär butyl nitron, seine salze und ihre verwendung als pharmazeutische radikalfänger | |
| AU2001288829A1 (en) | Degradable polyacetal polymers | |
| EP0598337A3 (en) | Medicinal compositions containing a drug, a cross-linked polymer, an oil, and a surfactant. | |
| AU2002218745A1 (en) | Particulate vectors for improving oral absorption of active principles | |
| DE69931925D1 (de) | 2-chinolonen enthaltende arzneimittel | |
| HRP20020929A2 (en) | Sustained release pharmaceutical cmpositions for parenteral administration of hydrophilic compounds | |
| DE69815094D1 (de) | 2-(iminoethyl)-aminophenyl - derivate, deren herstellung, deren verwendung als medikamente und diese enthaltende pharmazeutische zubereitungen | |
| EA004302B9 (ru) | β-КАРБОЛИНОВЫЕ ЛЕКАРСТВЕННЫЕ ПРОДУКТЫ | |
| AU8025998A (en) | Biologically active materials | |
| NO20011217D0 (no) | Doseringsform omfattende væskeformulering | |
| WO2003074033A8 (en) | Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping | |
| YU46503A (sh) | Farmaceutski oblik dronedarona za parenteralnu upotrebu | |
| CA2350659A1 (en) | Pharmaceutical composition for modified release insulin sensitiser | |
| ATE194909T1 (de) | Zusammensetzung mit natriumstärkeglycolat als grundlagenmaterial und daraus hergestellte produkte | |
| ATE219665T1 (de) | Dosisformen und deren verwendungen | |
| ATE158172T1 (de) | Pulverförmige pharmazeutische zusammensetzung | |
| DK0804165T3 (da) | Fast lægemiddelform med aktivt stof fordelt i polymert materiale | |
| AU2001262699A1 (en) | Biologically active agents and drugs | |
| HUP0301119A3 (en) | Biologically active agent and drug |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |